Centre Investigation Clinique- ICM
Paris, 75013, France
NCT Number: NCT03560089
To test the effects of a serious game rehabilitation programme in 50 patients with Parkinson's disease with gait and balance disorders in a randomised controlled study
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Paris, 75013, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serious game with movements
Serious game without movement
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 18 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Time frame: change between baseline and at 6 weeks
Institut National de la Santé Et de la Recherche Médicale, France
Other Gov
Serious Games Rehabilitation Programme to Treat Gant and Balance Disorders in Patients With Parkinson's Disease
Acronym: PARKGAME-II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT01496599
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03027310
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00001258
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial Details